ACI
DXCM icon

AMP Capital Investors’s DexCom DXCM Stock Holding History

AMP Capital Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-119,332
Closed -$16.3M – 434
2021
Q3 		$16.3M Sell
119,332
-26,908
-18% -$3.39M 0.09% 258
2021
Q2 		$15.6M Sell
146,240
-26,412
-15% -$2.54M 0.07% 296
2021
Q1 		$15.5M Sell
172,652
-11,252
-6% -$1.06M 0.08% 283
2020
Q4 		$16.7M Sell
183,904
-34,668
-16% -$3.1M 0.09% 256
2020
Q3 		$22M Buy
218,572
+25,384
+13% +$2.65M 0.13% 179
2020
Q2 		$19.2M Buy
193,188
+7,120
+4% +$637K 0.12% 196
2020
Q1 		$12.9M Buy
186,068
+77,796
+72% +$4.84M 0.1% 227
2019
Q4 		$5.85M Sell
108,272
-8,644
-7% -$410K 0.03% 524
2019
Q3 		$4.34M Sell
116,916
-119,392
-51% -$4.64M 0.02% 579
2019
Q2 		$8.61M Sell
236,308
-40,724
-15% -$1.28M 0.05% 393
2019
Q1 		$8.2M Buy
277,032
+172,604
+165% +$6.07M 0.05% 410
2018
Q4 		$3.09M Buy
+104,428
New +$3.31M 0.02% 613
2017
Q4 		– Sell
-81,232
Closed -$993K – 1191
2017
Q3 		$993K Hold
81,232
– – 0.01% 874
2017
Q2 		$1.49M Hold
81,232
– – 0.01% 776
2017
Q1 		$1.73M Hold
81,232
– – 0.01% 758
2016
Q4 		$1.23M Buy
+81,232
New +$1.44M 0.01% 833
2016
Q1 		– Sell
-24,140
Closed -$497K – 1199
2015
Q4 		$497K Sell
24,140
-7,860
-25% -$164K ﹤0.01% 981
2015
Q3 		$664K Buy
32,000
+13,108
+69% +$292K ﹤0.01% 912
2015
Q2 		$374K Buy
+18,892
New +$332K ﹤0.01% 1020
2014
Q4 		– Sell
-28,212
Closed -$292K – 1138
2014
Q3 		$292K Sell
28,212
-38,788
-58% -$396K ﹤0.01% 1062
2014
Q2 		$664K Sell
67,000
-972
-1% -$8.61K ﹤0.01% 972
2014
Q1 		$680K Buy
67,972
+36,992
+119% +$382K ﹤0.01% 931
2013
Q4 		$274K Buy
30,980
+1,416
+5% +$11.2K ﹤0.01% 1107
2013
Q3 		$201K Sell
29,564
-21,340
-42% -$135K ﹤0.01% 1140
2013
Q2 		$287K Buy
+50,904
New +$244K ﹤0.01% 1208

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AMP Capital Investors's DXCM Position: Q4 2021 in Review

AMP Capital Investors sold out of DexCom (DXCM) in Q4 2021, closing a stake of 119,332 shares — an estimated $16.3M sold.

AMP Capital Investors first reported a position in DXCM in Q2 2013 and held it in 25 quarters. The position peaked at $22M in Q3 2020. 931 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • AMP Capital Investors reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 119,332 DexCom shares in Q4 2021, an estimated $16.3M.
  • AMP Capital Investors first reported a position in DexCom in Q2 2013 and held it in 25 quarters.
  • AMP Capital Investors's DexCom position peaked at $22M in Q3 2020.
  • 931 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.